| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhat are the selected postoperative tear-film claim and original verdict?Required |
The selected claim is “Improved tear-film tests 60 days after cataract surgery,” with original grade C and note “Both tBUT and Schirmer differed substantially.” Subclaim score, status and axes are unrecorded and distinguished from the parent test/symptom C54 context. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Day-60 tear-film tests after cataract surgery; existing subclaim verdict |
Material needed: Detailed original material is needed on test definitions, surgical population, control, timing, denominators and question boundaries. Missing subclaim values are not filled from the parent. This records needed materials; no new research was executed. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Evidence conditionWho were the patients without pre-existing dry eye?Required |
The existing reader answer describes cataract patients without pre-existing dry eye. The other subclaim, “Treatment of chronic dry-eye disease in general,” retains grade ?. Results are not extended to patients with existing dry eye, other operations or all dry-eye disease. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Small-incision cataract surgery population; exclusion of pre-existing dry eye |
Material needed: Surgical and eligibility criteria, baseline tear-film measures and symptoms, excluded conditions and medicines, group baseline characteristics and actual eye/person denominators are needed. This records needed materials; no new research was executed. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionWhat are the original day-60 tBUT values and units?Required |
Day-60 tBUT is recorded as 13.9 seconds in the lactoferrin group and 7.86 seconds in the control group. Original values are preserved; between-group differences, relative improvement and CIs are not newly calculated. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Tear-breakup time; seconds; control |
Material needed: Test procedures and assessors, group baseline/follow-up values and denominators, adjustment, original effects, CIs, exact P values and rules for averaging repeated measurements are needed. This records needed materials; no new research was executed. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionIs Schirmer test 1 distinguished from tBUT?Required |
Day-60 Schirmer values are 30.9 mm with lactoferrin and 15.86 mm with control; the evidence-list endpoint is Schirmer test 1. Values in seconds, P values and effects from tBUT are not transferred to this test. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Tear test 1; millimeters; test conditions |
Material needed: Actual test methods, timing and conditions, baseline/follow-up tables, group denominators, effects, CIs, P values and tested-eye units are needed. No new instructions for performing the test are given. This records needed materials; no new research was executed. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionCan the OSDI symptom proportion substitute for tear-film tests?Required |
The preserved proportions with at least mild OSDI symptoms are 26.6% with lactoferrin and 42.8% with control. Symptom proportions, tBUT and Schirmer are separate endpoints; event counts, effects and CIs are not calculated from these percentages. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Objective tests; proportion with at least mild OSDI symptoms |
Material needed: OSDI categories, measurement time, valid denominators, original continuous scores and proportions, effects, CIs and prespecified hierarchy are needed. Objective-test changes are not automatically combined into symptom or functional success. This records needed materials; no new research was executed. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Evidence conditionWas lactoferrin added to routine postoperative care?Required |
The existing research description compares routine postoperative care alone with added lactoferrin. The counterview also records routine eye drops and natural recovery. This is not changed into a comparison of lactoferrin alone or replacement of routine eye drops. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Added oral lactoferrin; routine postoperative care |
Material needed: Materials on identical drops and postoperative care in each group, actual treatment changes, adherence, exposure and control procedures are needed. No instructions for surgery, drops, care or treatment replacement are given. This records needed materials; no new research was executed. |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Evidence conditionWhat do 350 mg/day, the day after surgery and 60 days describe?Required |
The original intervention and product descriptions record oral lactoferrin 350 mg/day for 60 days from the day after small-incision surgery. These identify research exposure and do not create new dosing, cumulative amounts, postoperative-care or product advice. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Oral formulation; research exposure; duration |
Material needed: Original product quantities, formulation and composition, actual exposure and adherence, controls and intervention deviations are needed. Cumulative amounts and doses are not newly calculated. This records needed materials; no new research was executed. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Evidence conditionDo other vitamin or omega-3 combinations have the same evidence?Required |
The existing product description states that efficacy of other vitamin or omega-3 combinations was not tested. Gaps in formulation, co-ingredients and manufacturing source remain; equivalence of ordinary products is not certified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Oral lactoferrin; boundaries between combinations and products |
Material needed: Materials on the original lactoferrin product, active quantity, composition, source, manufacture and actual control are needed. No product recommendations, combination-product effects or dosing advice are created. This records needed materials; no new research was executed. |
| 9 |
Partly verified |
Full text not readStored summary read |
N09 · Evidence conditionWhat are the 64 randomized patients, 58 completers and group denominators?Required |
The existing research description records 64 patients allocated 32 per group, with 6 not completing follow-up and 28 and 30 analyzed. Numbers and their original order are preserved; noncompletion rates and estimated event counts are not newly calculated. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
32 allocated per group; 28 and 30 analyzed; 6 noncompleters |
Material needed: Group allocation/completion/analysis flow, reasons and times of attrition, valid denominators for each test and OSDI, ITT and missing-data handling are needed. Detailed group tables were not compared this time. This records needed materials; no new research was executed. |
| 10 |
Unverified |
Full text not readStored summary read |
N10 · Evidence conditionAre people, operated eyes, both eyes and repeated tests the same unit?Required |
Counts in the existing summary refer to patients or participants. Detailed units for operated eyes, both eyes, selection of tested eyes, correlations between eyes and repeated tests are not established. Two eyes or repeated measurements from one person are not counted as independent participants. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Participant counts; tested eyes; analysis units |
Material needed: Operated side, tested eyes, person-eye links, original monocular/binocular denominators, eye-selection rules and correlation/repeated-measure analyses are needed. Eye counts and participant totals are not newly calculated. This records needed materials; no new research was executed. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Evidence conditionAre day-60 results distinguished from baseline, other times and persistence?Required |
Key numbers concern 60 days after surgery. Differences in changes from baseline, intermediate times, persistence after treatment and denominators at other times are separately unverified. Natural recovery and routine drops retain their original context; day-60 values are not transferred to other times. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Time-specific tests; natural recovery; persistence |
Material needed: Group baseline/intermediate/day-60/follow-up tables and denominators, between-group changes, CIs and concurrent surgical/drop care are needed. No new follow-up duration or effect is created. This records needed materials; no new research was executed. |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Evidence conditionHow were simple randomization, open-label design and no placebo recorded?Required |
The existing design is a single-center nonblinded simple-randomized parallel trial, with open-label, no-placebo completer analysis. Concordant directions in two objective tests do not certify absence of masking, allocation or measurement bias. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Allocation; masked assessment; concurrent care |
Material needed: Allocation methods and concealment, assessors and test procedures, matching routine care, missingness, selective reporting and original methods are needed. No new official RoB/GRADE rating or content-review approval is assigned. This records needed materials; no new research was executed. |
| 13 |
Unverified |
Full text not readStored summary read |
N13 · Evidence conditionAre exact effects and CIs for the large test differences verified?Required |
Original tBUT values of 13.9 and 7.86 seconds and Schirmer values of 30.9 and 15.86 mm are signals in two objective tests. Exact between-group/change effects, 95% CIs, P values, variance definitions and test denominators absent from this summary are not reconstructed. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original group values; adjusted/change estimates; precision |
Material needed: Test-specific original tables, between-group estimands, models, variance, CIs, P values, denominators and baseline adjustment are needed. No new effect sizes or hypothetical quantitative examples are created. This records needed materials; no new research was executed. |
| 14 |
Unverified |
Full text not readStored summary read |
N14 · Evidence conditionIs the prespecified hierarchy of both tests and OSDI verified?Required |
Existing endpoints list tBUT, Schirmer test 1 and OSDI together. Their prespecified primary/secondary hierarchy, multiplicity and registration identifiers/dates are separately unverified. No NCT identifiers or plan URLs are invented. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Primary/secondary endpoints; multiplicity; registration and plans |
Material needed: Registration, protocols, SAPs, amendment histories, test/symptom hierarchy, times and analysis-population materials are needed. Unread material is not converted into failed prespecification or absence of research. This records needed materials; no new research was executed. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Evidence conditionCan test improvement be extended to treatment of chronic dry eye in general?Required |
The existing summary and other subclaim retain exclusion of patients with pre-existing dry eye. Test signals are not established as the same efficacy for all chronic dry-eye disease, eye health, visual recovery or surgical outcomes. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Selected postoperative population; symptoms; function; applicability |
Material needed: Direct trials in each condition/population, patient-important symptoms and function, comparators, durations, effects and CIs are needed. No postoperative-care or dry-eye treatment instructions are given. This records needed materials; no new research was executed. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Harm-information gaps supplementing the efficacy tableIs nonreporting of some symptoms the same as long-term safety?Supplementary |
Existing explanations record no reported diarrhea, appetite loss, rash or constipation among 58 analyzed patients. This does not certify absence of all harms, long-term safety or the same safety in people with allergies, other illnesses or medicines. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Diarrhea, appetite loss, rash and constipation; collection scope |
Material needed: Harms-collection definitions and active surveillance, exposure and denominators per group, discontinuation, attrition, other harms and long-term population data are needed. No new harm rates, zero-event examples or treatment advice are created. This records needed materials; no new research was executed. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Evidence conditionWere the same trial, eyes and conditions kept out of independent-data totals?Required |
Parent verdict 2987 and its two subclaims share the same original-report context. Two sheets, tear-film tests, conditions, eyes and repeated measurements are not counted as new independent trials or participants. Unique-trial and unique-participant totals remain unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Shared parent, two subclaims, bibliography and participants |
Material needed: Links among reports, cohorts, people, eyes, times, conditions and analysis populations are needed. Material counts are not quality scores or unique-trial counts. This records needed materials; no new research was executed. |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Evidence conditionWhat material was actually read during this production?Required |
The complete parent-verdict JSON summary was read for production and preserved in its original form. External abstracts, full text, registration, protocols and SAPs remain unread. A source URL or PMCID does not establish actual access, reading or fulfillment of a condition. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Complete stored summary; external reading scope |
Material needed: Actual original texts, supplements, registration, plans and reading records are needed. Historical full-text verification is not inherited as external reading in this work. This records needed materials; no new research was executed. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Evidence conditionHow far are the original bibliography and registration identifiers linked?Required |
The original citation's PMID 26557550, PMCID PMC4625269, DOI 10.7860/JCDR/2015/15797.6670 and PubMed URL are linked. No separate registration number is present in the original evidence/citation; actual registration status remains unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
PMID, PMCID, DOI and registration information |
Material needed: Exact links among the paper, full text and registration, and materials on content and dates are needed. New full-text or registration URLs are not inferred from identifiers. This records needed materials; no new research was executed. |
| 20 |
Partly verified |
Full text not readStored summary read |
N20 · Evidence conditionAre historical verification statements in both languages distinguished from this review?Required |
Korean/English texts, subclaim and note, and historical statements about PMC full text, bibliography, effect-size and scoring checks are preserved. This work separates stored material; it is not a new clinical review, calculation or verdict. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Korean/English texts; existing claim; historical verification scope |
Material needed: Content review of original texts, translation, corrections and question boundaries is needed. Historical statements are not labeled as completed content review or independent clinical validation in this work. This records needed materials; no new research was executed. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Evidence conditionAre subclaim values distinguished from parent C54, axes and safety?Required |
Original subclaim grade C and note, and absence of subclaim score, status and axes are retained. Parent C54, Good safety, B/S/R1/I2/E+/B2, unrecorded precision, four false flags and empty override reasons are parent context. They do not fill subclaim values or certify long-term safety or independence. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Subclaim grade/note; absent score, status and axes |
Material needed: Content review of the selected record and original parent values is needed. No new efficacy grade, score, axes or regrading is created. This records needed materials; no new research was executed. |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Evidence conditionAre the evidence date, correction history and production date distinguished?Required |
The original evidence date 2026-09-07, empty corrections array and empty deliberation string are retained. The evidence date is not this production/review date and does not certify absence of external corrections. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Evidence date; empty correction and deliberation records |
Material needed: Actual follow-up/correction sources, complete prechange text and event histories are needed. Missing dates and correction values are not invented. This records needed materials; no new research was executed. |
| 23 |
Partly verified |
Full text not readStored summary read |
N23 · Evidence conditionAre funding, product support, employee authors and analysis roles distinguished?Required |
The original funding wording is “No financial or competing interests reported.” This is not new certification that product support, employee authors and involvement in analysis/reporting were all verified in detail. Original randomization/independence statements also remain historical records. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Four company-related aspects; historical independence statements |
Material needed: Original funding/COI declarations, product support, affiliations and analysis/publication roles are needed. Parent I2 is not promoted to new independence certification. This records needed materials; no new research was executed. |
| 24 |
Unverified |
Full text not readStored summary read |
N24 · Evidence conditionAre allocation, measurement, missingness and selective-reporting details verified?Required |
Open-label, no-placebo completer design and distinctions between objective tests and symptoms are retained. Details of allocation concealment, tested eyes, assessors, denominators, missingness and selective reporting are separately unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Design; endpoint hierarchy; denominators |
Material needed: Methods, protocols, SAPs, registration/amendment histories, original tables, effects of interest and denominators are needed. Design labels alone do not certify official RoB/GRADE ratings or review approval. This records needed materials; no new research was executed. |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Evidence conditionAre actual exposure, concurrent care and repeated measurements verified?Required |
Original oral 350 mg/day for 60 days added to routine postoperative care is preserved as research-identification information. Actual adherence, formulation, eye-drop care, treatment changes and endpoint-specific denominator details are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Research-intervention identity; adherence; co-interventions |
Material needed: Product/formulation quantities, actual exposure, concurrent care, intervention deviations and denominators are needed. No new cumulative calculation, intake, product, eye-health or postoperative-care instructions are created. This records needed materials; no new research was executed. |
| 26 |
Unverified |
Full text not readStored summary read |
N26 · Harm-information gaps supplementing the efficacy tableAre the scope of harms reports and actual denominators distinguished?Supplementary |
The existing record states no reported diarrhea, appetite loss, rash or constipation among 58 analyzed patients. Group-specific collection/exposure denominators, harms among those lost to follow-up and rates of other harms are separately unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Existing safety description; collection/exposure denominators |
Material needed: Harms definitions, active collection, actual group exposure/denominators, discontinuation, attrition, severity and original control materials are needed. Existing “Good” safety is not transferred to all populations and durations. This records needed materials; no new research was executed. |
| 27 |
Unverified |
Full text not readStored summary read |
N27 · Harm-information gaps supplementing the efficacy tableWhat are the boundaries for long-term/rare harms and other populations?Supplementary |
The existing safety description retains the limitation that 60-day postoperative completer results cannot establish long-term safety in people with milk-protein allergy, other illnesses or medicines. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original duration; illnesses; medicines; long-term scope |
Material needed: Long-term exposure/follow-up, harms surveillance, risk groups, medicines, group denominators, CIs and actual events are needed. No new treatment, intake, surgery or care instructions are given. This records needed materials; no new research was executed. |
| 28 |
Partly verified |
Full text not readStored summary read |
N28 · Evidence conditionWhat material would trigger a sheet update?Required |
This table transfers stored material on day-60 postoperative tear-film tests. Relevant observations can be updated after content review of original tables, measures, times, people, eyes, denominators, actual controls, concurrent care, follow-up, support and harms. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Distinguishing conditions, observations, original material and verdict changes |
Material needed: Complete prechange text and records of condition versions, separate application and content review are needed. Added material, revised conditions and verdict changes remain separate events; no new research, calculations or regrading are executed. This records needed materials; no new research was executed. |